| Identification | Back Directory | [Name]
L-Leucine, N-formyl-L-methionyl-L-isoleucyl-L-phenylalanyl- | [CAS]
112275-26-0 | [Synonyms]
L-Leucine, N-formyl-L-methionyl-L-isoleucyl-L-phenylalanyl- | [Molecular Formula]
C27H42N4O6S | [MOL File]
112275-26-0.mol | [Molecular Weight]
550.71 |
| Hazard Information | Back Directory | [Uses]
fMIFL is an FPR1 agonist. fMIFL can activate several signaling pathways responsible for various neutrophil functions, such as adhesion, chemotaxis, secretion of granule exocytosis, and the production of superoxide anions. fMIFL can be used in research on bacterial infections and tissue damage[1]. | [References]
[1] Dalpiaz A, et al. Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists. Curr Drug Targets Immune Endocr Metabol Disord. 2003 Mar;3(1):33-42. DOI:10.2174/1568008033340333 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|